chr17:37856333:> Detail (hg19) (ERBB2)

Information

Genome

Assembly Position
hg19 chr17:37,856,333-37,884,915
hg38 chr17:39,700,080-39,728,662 

HGVS

Type Transcript Protein
Summary

MGeND

Clinical significance
Variant entry
GWAS entry
Disease area statistics Show details

Frequency

[No Data.]

Prediction

[No Data.]

ClinVar

Clinical Significance
Review star [No Data.]
Show details
Links
Disease area statistics
[No Data.]
MGeND
[No Data.]
ClinVar
[No Data.]
CIViC
Disease Drug EL ET ED CS VO TR Pubmed Links
breast cancer Lapatinib B Predictive Supports Sensitivity/Response N/A 4 26811533 Detail
breast cancer B Prognostic Supports Poor Outcome N/A 3 26811533 Detail
DisGeNET
[No Data.]
Annotation

Annotations

DescrptionSourceLinks
Serum and tissue levels of HER2 (ERBB2) were analyzed in 1,902 breast cancer patients treated with l... CIViC Evidence Detail
Serum and tissue levels of HER2 (ERBB2) were analyzed in 1,902 breast cancer patients treated with l... CIViC Evidence Detail

Overlapped Transcript Coordinates

Gene Transcript ID Exon Number Chromosome Start Stop Type Amino Mutation Transcript Position Links

Overlapped Transcript

Gene Transcript ID Chromosome Start Stop Links
Gene
-
Genome
hg19
Position
chr17:37,856,333-37,884,915
Variant Type
snv
Variant (CIViC) (CIViC Variant)
SERUM LEVELS
Transcript 1 (CIViC Variant)
ENST00000269571.5
Variant URL (CIViC Variant)
https://civic.genome.wustl.edu/links/variants/416
Genome browser